Abbot Financial Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-10,650
| Closed | -$143K | – | 137 |
|
2021
Q3 | $143K | Buy |
+10,650
| New | +$143K | 0.07% | 132 |
|
2021
Q2 | – | Sell |
-8,650
| Closed | -$208K | – | 135 |
|
2021
Q1 | $208K | Buy |
+8,650
| New | +$208K | 0.09% | 127 |
|
2020
Q3 | – | Sell |
-8,350
| Closed | -$203K | – | 123 |
|
2020
Q2 | $203K | Buy |
+8,350
| New | +$203K | 0.14% | 105 |
|
2020
Q1 | – | Sell |
-8,550
| Closed | -$226K | – | 126 |
|
2019
Q4 | $226K | Buy |
+8,550
| New | +$226K | 0.14% | 115 |
|
2019
Q3 | – | Sell |
-8,550
| Closed | -$262K | – | 120 |
|
2019
Q2 | $262K | Buy |
+8,550
| New | +$262K | 0.19% | 104 |
|
2018
Q4 | – | Sell |
-8,800
| Closed | -$460K | – | 111 |
|
2018
Q3 | $460K | Hold |
8,800
| – | – | 0.34% | 73 |
|
2018
Q2 | $382K | Buy |
8,800
+300
| +4% | +$13K | 0.3% | 79 |
|
2018
Q1 | $315K | Buy |
+8,500
| New | +$315K | 0.25% | 85 |
|